Quest Offers Dementia Dx Panel for Treatable Forms of Cognitive Impairment
The test panel is believed to be the first commercial service from a clinical laboratory to combine several guideline-recommended tests for identifying secondary, treatable causes of dementia as a single blood test and report.
Read More